|
APEX2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.184500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.610300E-02 |
| Normal-vs-Stage2 |
1.333390E-01 |
| Normal-vs-Stage3 |
5.592500E-04 |
| Normal-vs-Stage4 |
7.332400E-01 |
| Stage1-vs-Stage2 |
8.616200E-01 |
| Stage1-vs-Stage3 |
4.964200E-03 |
| Stage1-vs-Stage4 |
2.197400E-01 |
| Stage2-vs-Stage3 |
1.262240E-02 |
| Stage2-vs-Stage4 |
1.998770E-01 |
| Stage3-vs-Stage4 |
1.904860E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.919280E-03 |
| Normal-vs-AfricanAmerican |
6.367800E-02 |
| Normal-vs-Asian |
2.476400E-01 |
| Caucasian-vs-AfricanAmerican |
3.359200E-01 |
| Caucasian-vs-Asian |
4.442800E-01 |
| AfricanAmerican-vs-Asian |
3.708000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.339980E-02 |
| Normal-vs-Female |
2.811000E-04 |
| Male-vs-Female |
1.783820E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.183620E-01 |
| Normal-vs-Extreme_Weight |
6.494400E-02 |
| Normal-vs-Obese |
9.157900E-03 |
| Normal-vs-Extreme_Obese |
2.574600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.016000E-01 |
| Normal_Weight-vs-Obese |
8.540400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.947000E-01 |
| Extreme_Weight-vs-Obese |
2.713800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.222600E-01 |
| Obese-vs-Extreme_Obese |
9.598800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.063200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.122700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.591900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.376230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.821100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.944800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.863700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.031400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.058400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.988400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.125900E-02 |
| Normal-VS-Type2 PRCC |
1.603540E-03 |
| Normal-VS-KIRP CIMP |
1.479750E-02 |
| Normal-VS-Unclassified PRCC |
1.072430E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.336100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.388000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.808000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.805010E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.688800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.348300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.646400E-02 |
| Normal-vs-N1 |
1.081650E-02 |
| Normal-vs-N2 |
2.473600E-01 |
| N0-vs-N1 |
1.700980E-01 |
| N0-vs-N2 |
6.301600E-01 |
| N1-vs-N2 |
8.521600E-01 |
|
|
